Experience of extensive vascular surgery on defibrase-defibrinogenated patients.
D000293:Adolescent; D000328:Adult; D012103:Batroxobin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001792:Blood Platelets; D005260:Female; D005268:Femoral Vein; D005338:Fibrin Fibrinogen Degradation Products; D005340:Fibrinogen; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D007084:Iliac Vein; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors; D014656:Vascular Surgical Procedures / Q000009:adverse effects*
D005338:Fibrin Fibrinogen Degradation Products; D005340:Fibrinogen; D010447:Peptide Hydrolases; D012103:Batroxobin